Hyperuricemia in Acute Coronary Syndrome Patients at Tertiary Care Hospital Peshawar.
DOI:
https://doi.org/10.35845/abms.2024.1.345Abstract
Objective
To investigate the affiliation between elevated uric acid and acute coronary syndrome.
Methods
This descriptive cross-sectional study was conducted over twelve months from June 2022 to May 2023 in the Cardiac Care Unit (CCU) and Pathology Laboratory of Kuwait Teaching Hospital. 201 patients were included, determined using the WHO sample size calculator. Inclusion criteria were patients with typical ischemic chest pain indicative of ACS, irrespective of gender and age, who were willing to participate. Data were collected using a structured preform questionnaire covering demographics, medical history, clinical presentation, and diagnostic findings. Key data included patient age, gender, history of hypertension, diabetes, hyperlipidemia, smoking status, family history of coronary artery disease, and symptoms at presentation. ACS was classified into STEMI, NSTEMI, or Unstable Angina based on ECG and troponin-I levels. Serum uric acid levels were measured after an eight-hour fasting period. Data were entered into Microsoft Excel and analyzed using SPSS version 25, employing descriptive statistics and Chi-square tests, with a p-value of <0.05 considered significant.
Results
A total 201 study participants were enrolled (average age: 57.5 years), with 99 (49%) males. Diabetes mellitus was found in 88 (44% of patients) and hypertension in 83 (41%). In 73 (36%) of the patients, hyperuricemia was seen. Males were more likely to have hyperuricemia (75%) than females 60 (59%), and diabetics were more likely to have it (80%) than hypertensive people 59 (71%). The overall incidence of hyperuricemia in ACS patients was 52%.
Conclusion
Our findings demonstrate the high prevalence of hyperuricemia in persons diagnosed with acute coronary syndrome. Routine monitoring and surveillance of blood uric acid levels in the general population appears to be a viable technique for proactively identifying and addressing anomalies promptly.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Muhammad Abdur Rauf, Shabina Shafiullah, Muhammad Abbas, Muhammad Ziyad, Muhammad Saleem Awan, Syed Tahir Shah
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may Share-copy and redistribute the material in any medium or format and Adapt-remix, transform, and build upon the material. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
. 
